NASDAQ:LQDA Liquidia (LQDA) Stock Price, News & Analysis $15.35 -0.21 (-1.35%) Closing price 05/23/2025 04:00 PM EasternExtended Trading$15.68 +0.34 (+2.18%) As of 05/23/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Liquidia Stock (NASDAQ:LQDA) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Liquidia alerts:Sign Up Key Stats Today's Range$15.01▼$17.8850-Day Range$11.99▼$19.3052-Week Range$8.26▼$19.41Volume4.74 million shsAverage Volume1.07 million shsMarket Capitalization$1.31 billionP/E RatioN/ADividend YieldN/APrice Target$25.56Consensus RatingBuy Company OverviewLiquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its lead product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD). The company also offers Remodulin, a treprostinil administered through continuous intravenous and subcutaneous infusion. The company also a license agreement with Pharmosa Biopharm Inc to develop and commercialize L606, an inhaled sustained-release formulation of Treprostinil for the treatment of PAH and PH-ILD. Liquidia Corporation was founded in 2004 and is headquartered in Morrisville, North Carolina.Read More… Liquidia Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks69th Percentile Overall ScoreLQDA MarketRank™: Liquidia scored higher than 69% of companies evaluated by MarketBeat, and ranked 292nd out of 919 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion4.5 / 5Analyst RatingBuy Consensus RatingLiquidia has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 6 buy ratings, no hold ratings, and 1 sell rating.Amount of Analyst CoverageLiquidia has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Liquidia's stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for Liquidia are expected to grow in the coming year, from ($1.51) to ($1.32) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Liquidia is -9.42, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Liquidia is -9.42, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioLiquidia has a P/B Ratio of 21.03. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about Liquidia's valuation and earnings. Short Interest0.0 / 5Short Interest LevelBearish Percentage of Shares Shorted15.84% of the outstanding shares of Liquidia have been sold short.Short Interest Ratio / Days to CoverLiquidia has a short interest ratio ("days to cover") of 12.5, which indicates bearish sentiment.Change versus previous monthShort interest in Liquidia has recently increased by 2.97%, indicating that investor sentiment is decreasing. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldLiquidia does not currently pay a dividend.Dividend GrowthLiquidia does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted15.84% of the outstanding shares of Liquidia have been sold short.Short Interest Ratio / Days to CoverLiquidia has a short interest ratio ("days to cover") of 12.5, which indicates bearish sentiment.Change versus previous monthShort interest in Liquidia has recently increased by 2.97%, indicating that investor sentiment is decreasing. News and Social Media3.8 / 5News Sentiment0.83 News SentimentLiquidia has a news sentiment score of 0.83. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.73 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 16 news articles for Liquidia this week, compared to 6 articles on an average week.Search Interest6 people have searched for LQDA on MarketBeat in the last 30 days. This is an increase of 200% compared to the previous 30 days.MarketBeat Follows2 people have added Liquidia to their MarketBeat watchlist in the last 30 days. This is an increase of 100% compared to the previous 30 days. Company Ownership4.2 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, Liquidia insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $450,233.00 in company stock.Percentage Held by Insiders26.50% of the stock of Liquidia is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions64.54% of the stock of Liquidia is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Liquidia's insider trading history. Receive LQDA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Liquidia and its competitors with MarketBeat's FREE daily newsletter. Email Address LQDA Stock News HeadlinesInsider Selling: Liquidia Co. (NASDAQ:LQDA) Insider Sells 2,450 Shares of StockApril 24, 2025 | insidertrades.comDrugmaker on verge of multibillion-dollar marketMay 23 at 7:16 PM | bizjournals.comMemorial Day Sale! 82% Off Disruptors and Dominators!Nvidia's robot breakthrough, unveiled by CEO Jensen Huang at CES, could spark a $24T revolution. He said the "ChatGPT moment" for robotics is near. I believe the lives of 65M Americans could be impacted – this year. And one $7 stock could be the biggest winner.May 24, 2025 | Weiss Ratings (Ad)U.S. FDA Approves Liquidia's YUTREPIA™ (treprostinil) Inhalation Powder for Patients with Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated with Interstitial Lung Disease (PH-ILD)May 23 at 2:28 PM | globenewswire.comOppenheimer Downgrades Liquidia (LQDA)May 20, 2025 | msn.comLiquidia (NASDAQ:LQDA) Downgraded to "Underperform" Rating by OppenheimerMay 20, 2025 | americanbankingnews.comHC Wainwright Estimates Liquidia's Q2 Earnings (NASDAQ:LQDA)May 17, 2025 | americanbankingnews.comLiquidia Corporation (NASDAQ:LQDA) Q1 2025 Earnings Call TranscriptMay 14, 2025 | insidermonkey.comSee More Headlines LQDA Stock Analysis - Frequently Asked Questions How have LQDA shares performed this year? Liquidia's stock was trading at $11.76 at the start of the year. Since then, LQDA shares have increased by 30.5% and is now trading at $15.35. View the best growth stocks for 2025 here. How were Liquidia's earnings last quarter? Liquidia Co. (NASDAQ:LQDA) posted its earnings results on Thursday, May, 8th. The company reported ($0.45) EPS for the quarter, missing the consensus estimate of ($0.42) by $0.03. The business earned $3.12 million during the quarter, compared to analyst estimates of $3.23 million. Liquidia had a negative net margin of 765.38% and a negative trailing twelve-month return on equity of 163.21%. Read the conference call transcript. When did Liquidia IPO? Liquidia (LQDA) raised $50 million in an initial public offering (IPO) on Thursday, July 26th 2018. The company issued 4,500,000 shares at a price of $10.00-$12.00 per share. Jefferies and Cowen served as the underwriters for the IPO and Needham & Company and Wedbush PacGrow were co-managers. Who are Liquidia's major shareholders? Liquidia's top institutional investors include Vanguard Group Inc. (4.06%), Vestal Point Capital LP (1.44%), Goldman Sachs Group Inc. (1.01%) and Boothbay Fund Management LLC (0.78%). Insiders that own company stock include Caligan Partners Lp, Roger Jeffs, Russell Schundler, Michael Kaseta, Rajeev Saggar, Robert A Lippe, Jason Adair and Scott Moomaw. View institutional ownership trends. How do I buy shares of Liquidia? Shares of LQDA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Liquidia own? Based on aggregate information from My MarketBeat watchlists, some other companies that Liquidia investors own include JPMorgan Chase & Co. (JPM), NVIDIA (NVDA), Ford Motor (F), Predictive Oncology (POAI), Tesla (TSLA), Advanced Micro Devices (AMD) and Abbott Laboratories (ABT). Company Calendar Last Earnings5/08/2025Today5/24/2025Next Earnings (Estimated)8/06/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Pharmaceutical preparations Sub-IndustryMedical Equipment Current SymbolNASDAQ:LQDA CIK1819576 Webwww.liquidia.com Phone(919) 328-4400FaxN/AEmployees50Year FoundedN/APrice Target and Rating Average Stock Price Target$25.56 High Stock Price Target$36.00 Low Stock Price Target$13.00 Potential Upside/Downside+66.5%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage9 Analysts Profitability EPS (Most Recent Fiscal Year)($1.58) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-78,500,000.00 Net Margins-765.38% Pretax Margin-765.38% Return on Equity-163.21% Return on Assets-67.14% Debt Debt-to-Equity RatioN/A Current Ratio6.33 Quick Ratio6.33 Sales & Book Value Annual Sales$14.14 million Price / Sales92.77 Cash FlowN/A Price / Cash FlowN/A Book Value$0.73 per share Price / Book21.03Miscellaneous Outstanding Shares85,485,000Free Float59,161,000Market Cap$1.31 billion OptionableOptionable Beta0.24 Investing Strategies To Help Grow Your Retirement IncomeNeed to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.Get This Free Report This page (NASDAQ:LQDA) was last updated on 5/24/2025 by MarketBeat.com Staff From Our PartnersTrump Predicts Dollar DownfallREAD THIS VERY CAREFULLY: If you have $100,000 or more saved for retirement, this may make you VERY angry... ...Augusta Precious Metals | Sponsored$19 for a FULL YEAR of stock picks?!Invest in Musk's AI Play With Just $100 You don't need deep pockets to ride the next wave of AI wealth. ...Behind the Markets | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredElon just did WHAT!?As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they got...Brownstone Research | SponsoredBanks aren’t ready for this altcoin—are you?While everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly po...Crypto 101 Media | SponsoredThe Hidden Energy Source Backed by Billionaires Why Billionaires Have Set Their Sights on the Utah Desert Something strange is happening near the Wah Wah ...Stansberry Research | SponsoredAfter Monday, price goes up 600% (hurry)Right now, for a limited time… You can get up to 52 Money Monday trades for just $7! Thanks to Wall Street’...Timothy Sykes | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Liquidia Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Liquidia With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.